At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
Exercise Treatmentother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
More Than Just p-Values: Minimal Clinically Important Difference for the Visual Analog Scale, Menstrual Symptom Questionnaire and Functional and Emotional Measure of Dysmenorrhea in Patients With Primary Dysmenorrhea
In Brief
A clinical study evaluating Exercise Treatment for Primary Dysmenorrhea and 2 related conditions. Completed, enrolled 100 participants across 1 site.
Detailed Summary
The aim of this study is to determine the Minimal Clinically Important Difference (MCID) for the Visual Analog Scale (VAS), Menstrual Symptom Questionnaire (MSQ), and Functional and Emotional Measure of Dysmenorrhea (FEMD) in patients with primary dysmenorrhea (PwPD).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrimary Dysmenorrhea, Pain, Menstrual Discomfort
CountriesTurkey (Türkiye)
Collaborators--
Timeline
N/ACompletedFinished
20252026
Enrollment StartFeb 2025
First PostedFeb 2025
Primary CompletionJul 2025
Study CompletionJul 2025
TodayJul 2026
First PostedFeb 19, 2025
Enrollment StartFeb 15, 2025
Primary CompletionJul 3, 2025
Study CompletionJul 31, 2025
TodayJul 1, 2026
Enrollment to primary: 5 monthsPosted 1.4 years ago
Interventions
Exercise Treatmentother
In this study, a functional exercise programme will be performed 3 days a week for 8 weeks in three cycles as previously recommended. This programme consisted of a 5-minute warm-up and a 45-minute exercise phase.